JP2024544566A5 - - Google Patents
Info
- Publication number
- JP2024544566A5 JP2024544566A5 JP2024528594A JP2024528594A JP2024544566A5 JP 2024544566 A5 JP2024544566 A5 JP 2024544566A5 JP 2024528594 A JP2024528594 A JP 2024528594A JP 2024528594 A JP2024528594 A JP 2024528594A JP 2024544566 A5 JP2024544566 A5 JP 2024544566A5
- Authority
- JP
- Japan
- Prior art keywords
- lentiviral vector
- acid sequence
- nucleic acid
- antigen
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306581.6 | 2021-11-15 | ||
| EP21306581 | 2021-11-15 | ||
| US202163279945P | 2021-11-16 | 2021-11-16 | |
| US63/279,945 | 2021-11-16 | ||
| EP22306119 | 2022-07-27 | ||
| EP22306119.3 | 2022-07-27 | ||
| PCT/EP2022/081839 WO2023084094A1 (en) | 2021-11-15 | 2022-11-14 | Lentiviral vectors for expression of human papillomavirus (hpv) antigens and its implementation in the treatment of hpv induced cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544566A JP2024544566A (ja) | 2024-12-03 |
| JP2024544566A5 true JP2024544566A5 (cg-RX-API-DMAC7.html) | 2025-10-14 |
Family
ID=84536137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024528594A Pending JP2024544566A (ja) | 2021-11-15 | 2022-11-14 | ヒトパピローマウイルス(hpv)抗原の発現の為のレンチウイルスベクター、並びにhpv誘発癌の処置におけるその実施 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240415951A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4433081A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024544566A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240124919A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022386715A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3238020A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023084094A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL318598A (en) * | 2022-07-27 | 2025-03-01 | Theravectys | Lentiviral vectors for the expression of human papillomavirus (HPV) antigens and their application in the treatment of HPV-induced cancer |
| CN116286982B (zh) * | 2022-09-09 | 2024-01-30 | 广州凯普医药科技有限公司 | 一种hpv基因分型检测阳性参考品及其制备方法和应用 |
| CN118344491B (zh) * | 2024-05-03 | 2025-02-14 | 华中科技大学同济医学院附属同济医院 | 一种hpv16/18治疗性疫苗、制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2337429T3 (es) | 1999-10-11 | 2010-04-23 | Institut Pasteur | Vectores lentivirales para la preparacion de composiciones inmunoterapeuticas. |
| ES2708856T3 (es) * | 2007-08-03 | 2019-04-11 | Pasteur Institut | Vectores de transferencia de gen lentivírico y sus aplicaciones medicinales |
| CN103772508B (zh) * | 2014-01-15 | 2017-05-10 | 深圳泰来生物医药有限公司 | 免疫增强的人乳头瘤病毒感染及相关疾病的治疗性疫苗 |
| CA2956385A1 (en) | 2014-07-25 | 2016-01-28 | Theravectys | Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule |
-
2022
- 2022-11-14 KR KR1020247019939A patent/KR20240124919A/ko active Pending
- 2022-11-14 JP JP2024528594A patent/JP2024544566A/ja active Pending
- 2022-11-14 WO PCT/EP2022/081839 patent/WO2023084094A1/en not_active Ceased
- 2022-11-14 AU AU2022386715A patent/AU2022386715A1/en active Pending
- 2022-11-14 CA CA3238020A patent/CA3238020A1/en active Pending
- 2022-11-14 EP EP22823328.4A patent/EP4433081A1/en active Pending
- 2022-11-14 US US18/706,610 patent/US20240415951A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8389275B2 (en) | Fusion proteins of HIV regulatory/accessory proteins | |
| JP6655051B2 (ja) | 発癌性ウイルスポリペプチド陽性腫瘍治療用ポリヌクレオチド | |
| JP2019526580A5 (cg-RX-API-DMAC7.html) | ||
| US20130302367A1 (en) | Virus vector for prime/boost vaccines, which comprises vaccinia virus vector and sendai virus vector | |
| JP2010535495A5 (cg-RX-API-DMAC7.html) | ||
| CN102046785A (zh) | 基于慢病毒的免疫原性载体 | |
| US20190151437A1 (en) | Combination prime: boost therapy | |
| Malkevitch et al. | A call for replicating vector prime-protein boost strategies in HIV vaccine design | |
| CN104039968B (zh) | 非b亚型gag蛋白在慢病毒包装中的应用 | |
| JP2021506300A (ja) | B型肝炎ウイルス(hbv)に対する免疫応答を誘導するための方法および組成物 | |
| Xu et al. | Prime-boost vaccination with recombinant mumps virus and recombinant vesicular stomatitis virus vectors elicits an enhanced human immunodeficiency virus type 1 Gag-specific cellular immune response in rhesus macaques | |
| Tallet et al. | Sequence variations in the amino-and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies | |
| RU2697781C2 (ru) | Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека | |
| JP2010168288A (ja) | 最適化した抗原遺伝子の使用によるウイルスワクチンの免疫原性の増強 | |
| during Assembly | Polyprotein Processing | |
| Letvin et al. | A Human T-Cell Leukemia Virus Type | |
| CN118354790A (zh) | 用于表达人乳头瘤病毒(hpv)抗原的慢病毒载体及其在治疗hpv诱发癌症中的应用 | |
| McKenna | Characterization and immunogenicity of recombinant rhabdoviral vaccine vectors expressing HIV-1 and SIV envelope proteins | |
| Cohen | ANIMAL VIRUSES | |
| Ertl et al. | Induction of CD8+ T Cells to an HIV-1 | |
| JP2010248179A (ja) | 医薬組成物 |